Clinical treatment – Page 5 – Communicable Diseases Research

Genome-wide association study of COVID-19 severity among the Chinese population

Article

Published on 2021-08-312022-10-04
Journal: Cell Discovery [Category] 유전자 메커니즘, 임상,

[키워드] 95% CI 95% confidence interval acute respiratory syndrome Asian association C11orf71 CADM1 cause China Chinese chromosome Clinical treatment Cohort complex interaction components controls coronavirus coronavirus disease COVID-19 COVID-19 cohort COVID-19 severity critical COVID-19 patient CTSC disease eQTL Genetic genetic determinant Genome-wide association studies Genome-wide association study highlight hospital hospitals Host Infection loci Meta-analysis microbial Mild moderate NNMT Odds ratio Pathogenesis Patient performed Population Population genetics REXO2 SARS-CoV-2 severity of COVID-19 significantly susceptibility union Wuhan
[DOI] 10.1038/s41421-021-00318-6 PMC 바로가기 [Article Type] Article

Artemether, Artesunate, Arteannuin B, Echinatin, Licochalcone B and Andrographolide Effectively Inhibit SARS-CoV-2 and Related Viruses In Vitro

Artemether, Artesunate, Arteannuin B, Echinatin, Licochalcone B 및 Andrographolide는 시험관 내에서 SARS-CoV-2 및 관련 바이러스를 효과적으로 억제합니다

Cellular and Infection Microbiology

Published on 2021-08-302022-09-11
Journal: Frontiers in Cellular and Infection Microbiology [Category] MERS, SARS, 변종,

Therapeutic potential of anticoagulant therapy in association with cytokine storm inhibition in severe cases of COVID-19: A case report

Case Report

Published on 2021-08-232022-10-28
Journal: Open Life Sciences [Category] COVID-19,

A staged approach to address youth unresponsive to initial obesity intervention: a randomized clinical trial

Research

Published on 2021-08-202022-10-05
Journal: International journal of obesity (2005) [Category] 임상,

Severity-associated markers and assessment model for predicting the severity of COVID-19: a retrospective study in Hangzhou, China

Covid-19의 심각성을 예측하기위한 심각도 관련 마커 및 평가 모델 : 중국 항저우의 후 향적 연구

Research Article

Published on 2021-08-092022-09-10
Journal: BMC Infectious Diseases [Category] MERS, SARS, 바이오마커,

[키워드] 95% CI Admission albumin assessment Assessment model AUROC AUROCs best bootstrap C-reactive protein calibration curve China clinical decision clinical marker Clinical practice Clinical treatment clinician Coagulation coagulation function Comorbidity COVID-19 COVID-19 patient COVID-19 patients Critical cutoff value Decision making develop eight electrolyte disturbance enrolled eosinophil evaluate external validation Fever help hospital internal internal and external Laboratory Lactate lactate dehydrogenase LASSO likelihood Logistic regression lymphocyte Lymphocyte count lymphocyte counts marker measure ordinal logistic regression Patient prediction Prognosis random Random forest Receiver operator characteristic Regression model Result Retrospective study risk sampling Selection Sensitivity and specificity severity severity of COVID-19 Shrinkage supplementary material Support support vector machine training set was performed was used Web-based assessment system
[DOI] 10.1186/s12879-021-06509-6 PMC 바로가기 [Article Type] Research Article

Effectiveness and safety of different traditional Chinese medicines for Coronavirus disease 2019 A protocol for systematic review and network meta-analysis

코로나 바이러스 질병 2019에 대한 다른 전통적인 중국 의약품의 효과 및 안전성 및 네트워크 메타 분석을위한 프로토콜

3800

Published on 2021-08-062022-08-31
Journal: Medicine [Category] COVID-19, MERS, meta-analysis,

Public expenditure on hospitalizations for COVID-19 treatment in 2020, in Brazil

Original Article

Published on 2021-08-042022-10-29
Journal: Revista de Saúde Pública [Category] COVID-19, MERS, SARS,

[키워드] average Brazil cause Clinical treatment Coronavirus infection Coronavirus infections costly COVID-19 Custos Hospitalares diagnosed with COVID-19 distribution evaluated exceeded Gastos Públicos com Saúde Government highest hospital hospital costs Hospitalização Hospitalization hospitalizations ICD-10 Infecções por Coronavirus infecção Influenza lethality rate pelo coronavírus Pneumonia Public Public Expenditures on Health recorded reduce Region regions Registered resources Respiratory failure resulting Sistema Único de Saúde South SUS System Total treating COVID-19 Treatment turn Unified Health System
[DOI] 10.11606/s1518-8787.2021055003666 PMC 바로가기 [Article Type] Original Article

Long Noncoding RNAs as Emerging Regulators of COVID-19

COVID-19의 새로운 조절자로서의 긴 비코딩 RNA

Review

Published on 2021-08-022022-09-11
Journal: Frontiers in Immunology [Category] MERS, SARS, 바이오마커, 유전자 메커니즘, 치료제,

[키워드] (Tocilizumab) acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 Antiviral antiviral immune response antiviral immune responses antiviral role biological processe biological processes cellular changes in Clinical treatment coronavirus disease Coronavirus disease 2019 Coronavirus-2 COVID-19 COVID-19 treatment death Dexamethasone disease drug Evidence expression glucocorticoid Glucocorticoids help Host host transcriptome immune dysfunction Immune escape immune responses incidence rate indicate Infection Inflammatory response inhibiting interferons involved lncRNA lncRNAs Long long noncoding RNA mechanisms monoclonal antibodies monoclonal antibody Occurrence pandemic pathology regulate Regulation regulator Research respiratory resulting RNA SARS-CoV-2 SARS-COV-2 infection Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus-2 Spread subsequent therapeutic thrombosis Tocilizumab Transcriptome Treatment type I interferon type I interferons up-regulate Viral viral gene viral genes viral infections viral replication virus infection virus infections
[DOI] 10.3389/fimmu.2021.700184 PMC 바로가기 [Article Type] Review

Current status of traditional Chinese medicine for the treatment of COVID-19 in China

Review

Published on 2021-07-272022-11-01
Journal: Chinese Medicine [Category] COVID-19,

The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections

Review

Published on 2021-07-232022-10-29
Journal: International Review of Cell and Molecular Biology [Category] COVID-19,

[키워드] arising B.1.1.7 CCL2 changes in clinical Clinical treatment clinical trial clotting factor community transmission convalescent Convalescent plasma therapy coronavirus Coverage COVID-19 COVID-19 convalescent therapy COVID-19 therapy COVID-19 vaccine cytokine diagnosis of COVID-19 disease disease severity Ebola effective H1N1 influenza host response human antibodies IL-17 IL-1β IL-2 IL-6 IL-8 immunological impacted IMPROVE include Infection initial Major management mitigate multiple mutation Neutralizing antibodies novel outbreak pandemic pandemic progresses PCR plasma resulting risk role SARS-CoV-2 SARS-COV-2 infection successive wave survival rate therapy TNFα Treatment Trial unvaccinated population vaccination variant variants of concern viral challenge virulence virulent virus
[DOI] 10.3390/life11080734 PMC 바로가기 [Article Type] Review